BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
371 – 380 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Master protocols in clinical trials : a universal Swiss Army knife?
(
- Contribution to journal › Scientific review
-
Mark
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Either Rap1 or Cdc13 can protect telomeric single-stranded 3' overhangs from degradation in vitro.
(
- Contribution to journal › Article
-
Mark
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
(
- Contribution to journal › Article
-
Mark
Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
-
Mark
Differential impedance spectra analysis reveals optimal actuation frequency in bulk mode acoustophoresis
(
- Contribution to journal › Article
-
Mark
Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
(
- Contribution to journal › Article
-
Mark
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
(
- Contribution to journal › Article